Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus vs CNI in Maintenance Liver Transplant Recipients
NCT00267189Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of everolimus in Liver transplant rejection, sponsored by Novartis. Started Nov 2005; status: completed.
02
Drugs
everolimus
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00267189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00267189.